Empowering the Next Leap: Redcliffe Labs Appoints Rohit Jalan as Chief Investment Officer
New Delhi, August 07, 2025: Redcliffe Labs, a pan-India purpose-driven diagnostics network, has announced the appointment of Rohit Jalan as its new Chief Investment Officer (CIO). In this critical leadership role, Rohit will be responsible for driving Redcliffe’s capital strategy, leading inorganic growth initiatives, and laying the groundwork for the company’s IPO readiness.
As CIO, Rohit will steer strategic M&A, oversee pre-IPO fundraising, manage investor relations, and help shape the company’s public market narrative. With over two decades of experience across investment banking, M&A, corporate development, and having been involved in 10+ successful public listings, Rohit brings a sharp strategic lens and deep financial acumen to the leadership team. His successful leadership as the Chief Business Officer- Inorganic, where he led Redcliffe’s Series C fundraise and executed multiple high-impact acquisitions across India, instills confidence in his ability to steer Redcliffe’s growth.
Aditya Kandoi, CEO and Founder, Redcliffe Labs, said, “Rohit has been a key force behind our strategic growth journey, especially in scaling Redcliffe through well-timed acquisitions and capital partnerships. His elevation to CIO is a crucial progression as we prepare for our next chapter, one that demands sharper capital stewardship, market readiness, and long-term value creation. His leadership will be instrumental in aligning Redcliffe’s growth ambitions with investor trust and sustained performance.”
Even as we scale new heights, our unwavering commitment to a customer-first approach and building a Healthier Bharat will always remain at the heart of everything we do. We value our customers, and their health is our top priority.
Rohit Jalan, in his new role as CIO, expressed his excitement and humility. He shared, “Over the past few years at Redcliffe, I’ve had the opportunity to lead some of our most transformative milestones, from driving strategic acquisitions to securing key funding rounds. Stepping into the role of CIO at such a crucial juncture is both exciting and humbling. As we prepare for the next phase of growth, my focus will be on scaling our capital strategy, deepening investor relationships, and unlocking long-term value for all stakeholders.”
I look forward to meaningfully advancing Redcliffe’s journey of democratising quality diagnostics, while helping shape a future-resilient healthcare organisation anchored in purpose and progress.”
This appointment comes at a pivotal time as Redcliffe Labs strengthens its commitment to taking diagnostics closer to every Indian through clinical rigour, technology-led innovation, and a leadership team rooted in purpose. As the company expands its footprint across Bharat alike, it continues to redefine the diagnostics experience, one that is not just accessible, but also empathetic, outcome-driven, and built for the future of healthcare.”